How to Apply
Applicants interested in applying can visit our Application page for more details and to download the application.
Welcome from our Program Director, Dr. Elizabeth Hexner:
The Cell Therapy and Transplantation Program at Penn Medicine’s Abramson Cancer Center is committed to Research, Clinical care and educating clinician-scientists in new discoveries and advances in cell and gene therapies. Penn Medicine leads the world in CAR T therapy and other advances in Blood Cancers and is proud to share knowledge with interested clinician-scientists from around the Globe. Conveniently located in Philadelphia, Pennsylvania, Penn Medicine has a deep history rooted in the founding of the First Teaching Hospital in the U.S.A., The Hospital of the University of Pennsylvania. Philadelphia is home to the First FDA-Approved Cell and Gene Therapies.
Why Penn Medicine?
Penn Medicine is the international leader in cell and gene therapy research and development. Thanks to longstanding faculty researchers, including Carl June, Jim Wilson, Jean Bennett and Bruce Levine, and a new group of emerging faculty innovators, Penn has helped propel Philadelphia to be called Cellicon Valley. This distinction stems from:
- The launch of at least 10 startups that in and of themselves have raised over $650 million in investment capital. Notable names on this list include: Spark Therapeutics (Drs.Bennett & Maguire), Tmunity Therapeutics (Dr. June), Carisma Therapeutics (Dr. Gill), Cabaletta Bio (Drs. Payne and Milone), ReGenX Bio, Scout Bio & Passage Bio (Dr. Wilson)
- The launch of 15 major Industry Alliances in the cell and gene therapy space that have generated almost $500 million US Dollars in sponsored research dollar support back to Penn to date
- Ranked 1st among global universities for CAR-T cell patents according to Nature: 428 patents for 54 separate T-cell inventions
Trainee activities at Penn Medicine and the University of Pennsylvania are governed by the University of Pennsylvania Rules and Regulations, including the institutional Intellectual Property Policy. Trainees will be expected to maintain the confidentiality of University proprietary information, and to obtain approval from their program director prior to disclosing or publishing any results of their activities at Penn Medicine.
We look forward to welcoming you to Penn Medicine!
Sincerely,
Elizabeth Hexner, MD MSTR
Dr. Hexner has two major research interests in malignant hematology: cellular therapies/ hematopoietic stem cell transplantation, and experimental therapeutics in myeloproliferative neoplasms (MPN). Both have a translational focus and align with her clinical roles as Medical Director of the Center for Cellular Immunotherapies and as Director of the MPN program at the University of Pennsylvania. She also serves as the Associate Director of the NIH CTSA-funded Masters in Translational Research program, where she co-directs a graduate level course in cell and gene therapy.
Heme team
Elizabeth Hexner, MD MSTR
Associate Professor of Medicine
Medical Director, Center for Cellular Immunotherapies
Research Expertise: Myeloproliferative Disorders, Umbilical Cord Blood Transplantation
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Classical Hematology Program, Hematology Malignancies Program, Leukemia Program
David Porter, MD
Director, Cell Therapy and Transplantation
Jodi Fisher Horowitz Professor in Leukemia Care Excellence
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program, Lymphoma Program
Stephen Schuster, MD
Robert and Margarita Louis‐Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research
Director, Lymphoma Program
Director, Lymphoma Translational Research
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Lymphoma Program
Edward A. Stadtmauer, MD
Section Chief, Hematologic Malignancies
Roseman, Tarte, Harrow, and Shaffer Families' President's Distinguished Professor
Program/Specialty: Amyloidosis Program, Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program, Lymphoma Program, Multiple Myeloma Program, Virtual Visits
Noelle Frey, MD, MS
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Director of Clinical Cellular Therapy, Cell and Transplant Therapy Program
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program
Saar Gill, MD, PhD
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Scientific Co‐Director, Cell Therapy and Transplant Program
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program, Leukemia Program, Classical (Non‐ Malignant) Hematology Program
Selina M. Luger, MD
Professor of Medicine at the Hospital of the University of Pennsylvania
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program
Sunita Nasta, MD
Chair, Clinical Trials Review Monitoring Committee
Associate Professor of Clinical Medicine
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Classical (Non‐Malignant) Hematology Program, Hematological Malignancies (Blood Cancer) Program, Lymphoma Program
Adam Cohen, MD
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Director, Myeloma Immunotherapy
Program/Specialty: Amyloidosis Program, Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Lymphoma Program, Multiple Myeloma
Alfred Garfall, MD
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Program/Specialty: Amyloidosis Program, Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Multiple Myeloma
Alison Wakoff Loren, MD, MSCE
Director, Blood and Marrow Transplantation
Vice Chair, Faculty Development, Department of Medicine
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program, Leukemia Program
Daniel Landsburg, MD
Medical Director of Infusion Services, Hospital of the University of Pennsylvania
Vice Chief of Quality and Safety, Division of Hematology/Oncology
Assistant Professor of Clinical Medicine
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Lymphoma Program
Alexander E Perl, MD
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Multiple Myeloma, Classical (Non‐ Malignant) Hematology Program
Jakub Svoboda, MD
Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, LGBT Health Program, Classical (Non‐ Malignant) Hematology Program, Lymphoma Program, Virtual Visits
Dan Vogl, MD, MSCE
Director, Abramson Cancer Center Clinical Research Unit (CRU)
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Multiple Myeloma, Classical (Non‐Malignant) Hematology Program, Amyloidosis Program
Daria V. Babushok, MD, PhD
Assistant Professor of Medicine
Assistant Professor of Pediatrics
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program
Mary Ellen Martin, MD, FACP
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program
Shannon Mccurdy, MD
Assistant Professor of Medicine at the Hospital of University of Pennsylvania
Program/Specialty: Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Leukemia Program
Keith Pratz, MD
Director, Leukemia Program
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Adam Waxman, MD, MS
Assistant Professor of Clinical Medicine
Program/Specialty: Amyloidosis Program, Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program, Multiple Myeloma Program
Stefan Barta, MD, MS, MRCPCUK
Director, T‐Cell Lymphoma Program
Executive Office, AIDS Malignancy Consortium
Associate Professor of Clinical Medicine
Kyle Robinson, MD
Assistant Professor of Clinical Medicine
Program/Specialty: Lymphoma Program